US health plans survive Biogen motion to dismiss with Robinson-Patman claims
US health benefit plans suing Biogen for allegedly bribing pharmacy benefit managers and unlawfully impairing competition from generic versions of Tecfidera overcame Biogen’s motion to dismiss by dropping claims for damages...To view the full article, register now.
Already a subscriber? Click here to view full article